Journal Information
Vol. 7. Issue 2.
Pages 130-134 (March - April 2011)
Share
Share
Download PDF
More article options
Vol. 7. Issue 2.
Pages 130-134 (March - April 2011)
Review
Full text access
Sjögren's syndrome and pancreatic affection
Afección pancreática en el síndrome de Sjögren
Visits
8576
Gabriela Hernández-Molina
Corresponding author
gabyhm@yahoo.com

Corresponding author.
, Martha L. Michel-Peregrina
Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
This item has received
Article information
Abstract

Sjögren's syndrome (SS) is an autoimmune disorder affecting primarily the exocrine glands, leading to keratoconjunctivitis sicca (KCS) and xerostomia, but that can also include extraglandular features1. Due the anatomical, physiological and pathological similarity between the pancreas and the salivary glands, it has been described that the pancreas it is not exempt from the damage produced by this syndrome. Some authors have assessed pancreatic involvement of SS by analyzing the histopathological changes, evaluating the pancreatic endocrine and exocrine function (serum pancreatic enzymes, elastase, lipase or trypsin determinations, N-benzoyl-L-tyrosyl-para-aminobenzoic acid excretion test, etc), searching specific pancreatic antibodies (antiductal) or performing endoscopic retrograde colangiopancreatography or noninvasive imaging studies such as computed tomography or ultrasound. Herein we review the literature regarding the prevalence and type of pancreatic involvement in the SS and we discuss the differential diagnosis with multiorganic Lymphoproliferative Syndrome.

Keywords:
Sjögren's Syndrome Exocrine pancreass
Resumen

El síndrome de Sjögren (SS) es una enfermedad autoinmunitaria que afecta principalmente a las glándulas exocrinas, aunque puede ocasionar también manifestaciones extraglandulares. Dada la similitud anatómica, fisiológica y patológica del páncreas y las glándulas salivales, se ha descrito que el páncreas no está exento del daño producido por el síndrome de Sjögren. Por esta similitud, algunos autores han estudiado la influencia del SS en el páncreas analizando los cambios histopatológicos, evaluando la función pancreática endocrina y exocrina (medición de enzimas pancreáticas séricas, prueba de excreción de ácido N-benzoil-Ltirosil- para-aminobenzoico, medición de elastasa, lipasa o tripsina), por la detección de anticuerpos específicos para páncreas (Ac. anticonductos), o mediante la realización de colangiopancreatografía endoscópica retrógrada o estudios de imagen no invasivos (tomografía computarizada y ultrasonido). En el presente trabajo revisamos la literatura científica en relación con la prevalencia y el grado de afección pancreática en SS y discutimos sobre el diagnóstico diferencial con el síndrome linfoproliferativo multiorgánico.

Palabras clave:
Síndrome de Sjögren Páncreas exocrino
Full text is only aviable in PDF
References
[1.]
M. Ramos-Casals, J. Font.
Primary Sjögren's Syndrome: current and emergent aetiopathogenic concepts.
Rheumatology, 44 (2005), pp. 1354-1367
[2.]
M. Ramos-Casals, R. Solans, J. Rosas, M. Camps, A. Gil, J. Del Pino-Montes, et al.
Primary Sjögren syndrome in Spain. Clinical and immunologic expression in 1010 patients.
Medicine, 87 (2008), pp. 210-219
[3.]
R. Fox, F. Howell, R. Bone, P. Michelson.
Primary Sjögren Syndrome: clinical and immunopathologic features.
Semin Arthritis Rheum, 14 (1984), pp. 77-105
[4.]
S. Sheik, T. Shaw-Stiffel.
The gastrointestinal manifestations of Sjögren's syndrome.
AJG, 90 (1995), pp. 9-14
[5.]
S. Constantopoulos, V. Tsianos, H. Moutsopoulos.
Pulmonary and gastrointestinal manifestations of Sjögren's syndrome.
Rheum Dis Clin Nort, 18 (1992), pp. 617-635
[6.]
T. Fukui, K. Okazaki, H. Yoshizawa, S. Ohashi, H. Tamaki, K. Kawasaki, et al.
A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjögren's syndrome.
Pancreatology, 5 (2005), pp. 86-89
[7.]
H. Ohara, T. Nakazawa, H. Sano, T. Ando, T. Okamoto, H. Takada, et al.
Systemic extrapancreatic lesions associated with autoimmune pancreatitis.
Páncreas, 31 (2005), pp. 232-237
[8.]
T. Pickartz, H. Pickartz, H. Lochs, J. Ockenga.
Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjögren's syndrome.
Eur J Gastroenterol Hepatol, 16 (2004), pp. 1295-1299
[9.]
R. Eckstein, R. Hollings, P. Martín, C. Katelaris.
Pancreatic pseudotumor arising in association with Sjögren's syndrome.
Pathology, 27 (1995), pp. 284-288
[10.]
I. Nishimori, K. Okazaki, Y. Yamamoto, M. Morita, S. Tamura, Y. Yamamoto.
Specific cellular immune responses to pancreatic antigen in chronic pancreatitis ad Sjögren's syndrome.
J Clin Immunol, 13 (1993), pp. 265-271
[11.]
H. Ludwig, G. Swchernthaner, O. Scherak, G. Kolarz.
Antibodies to pancreatic duct cells in Sjögren's syndrome and rheumatoid arthritis.
Gut, 18 (1977), pp. 311-315
[12.]
I. Nishimori, K. Okazaki, Y. Yamamoto, M. Morita, S. Tamura, Y. Yamamoto.
Sensitization against pancreatic antigen in Sjögren syndrome and chronic pancreatitis.
Digestión, 51 (1992), pp. 71-74
[13.]
G. Sundkvist, G. Lindahlg, P. Koskinene, J. Bolinder.
Pancreatic autoantibodies and pancreatic function in Sjögren's syndrome.
Int J Pancreatol, 8 (1991), pp. 141-149
[14.]
E.B. Tsianos, A. Tzioufas, M. Kita, O. Tsolas, H. Moutsopoulos.
Serum isoamylases in patients with autoimmune rheumatic diseases.
Clin Exp Rheumatol, 2 (1984), pp. 235
[15.]
P.A. Ostuni, G. Gazzetto, F. Chieco-Bianchi, B. Riga, M. Plebani, C. Betterle, et al.
Pancreatic exocrine involvement in primary Sjögren's syndrome Scand.
J Rheumatol, 25 (1996), pp. 47-51
[16.]
F. Fenster, W. Buchanan, L. Laster, J. Bunim.
Studies of pancreatic function in Sjögren's syndrome.
Annals Intern Med, 61 (1964), pp. 498-508
[17.]
L. Szanto, K. Farkas, E. Gyulai.
On Sjögren disease.
Rheumatism, 13 (1957), pp. 60-63
[18.]
U.G. Bucher, L. Reid.
Sjogren's syndrome: report of a fatal case with pulmonary and renal lesions.
Br J Dis Chest, 53 (1959), pp. 237-252
[19.]
J. Coll, S. Navarro, R. Tomas, M. Elena, E. Martinez.
Exocrine pancreatic function in Sjögren's syndrome.
Arch Intern Med, 149 (1989), pp. 848-852
[20.]
K. Kawaguchi, M. Koike, K. Tsuruta, A. Okamoto, I. Tabata, N. Fujita.
Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas.
Hum Pathol, 14 (1991), pp. 14-15
[21.]
D. Sahani, N. Sainani, V. Deshpande, M. Shaikh, D. Frinkelberg, C. Fernández-del Castillo.
Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy.
Radiology, 250 (2009), pp. 118-129
[22.]
T. Hayakawa, S. Naruse, M. Kitagawa, T. Kondo.
Clinical aspects of autoimmune pancreatitis in Sjögren's syndrome.
JOP, 2 (2001), pp. 88-92
[23.]
I. Nishimori, M. Morita, J. Kino, J. Onodera, Y. Nakazawa, K. Okazaki, et al.
Pancreatic involvement in patients with Sjögren‘s syndrome and primary billiary cirrhosis.
Int J Pancreatol, 1 (1995), pp. 47-54
[24.]
P. Afzelius, E. Fellentin, S. Larsen, S. Moller, M. Schiodt.
Pancreatic function and morphology in Sjögren's syndrome Scand.
J Gastroenterol, 45 (2010), pp. 752-758
[25.]
D.A. Dreiling, J.M. Soto.
The pancreatic involvement in disseminated collagen disorders. Studies of pancreatic secretion in patients with scleroderma and Sjögren's disease.
Am J Gastroenterol, 66 (1976), pp. 546-553
[26.]
M. Hradsky, V. Bartos, O. Keller.
Pancreatic function in Sjögren's syndrome.
Gastroenterologia, 108 (1967), pp. 252-260
[27.]
A. D’Ambrosi, A. Verzola, P. Gennaro, S. Gatto, M. Catellani, R. LaCorte.
Functional reserve of the exocrine pancreas in Sjögren's syndrome.
Recenti Prog Med, 88 (1997), pp. 21-25
[28.]
P.G. Lankishc, C. Arglebe, R. Chilla.
Pancreatic function in Sjögren‘s syndrome.
Dig Dis Sci, 33 (1988), pp. 11
[29.]
C. Gobelet, J.C. Gerster, G. Rappoport, C.A. Hiroz, E. Maeder.
A controlled study of the exocrine pancreatic function in Sjögren‘s syndrome and rheumatoid arthritis.
Clin Rheumatol, 2 (1983), pp. 139-143
[30.]
C. Kelly, A. Katrak, I. Griffiths.
Pancreatic function in patients with primary Sjögren's syndrome.
Br J Rheumatology, 32 (1993), pp. 169-174
[31.]
H. Witt, M. Apte, V. Keim, J. Wilson.
Chronic pancreatitis: Challenges and advances in pathogenesis, genetics, diagnosis and therapy.
Gastroenterology, 132 (2007), pp. 1557-1573
[32.]
T. Bozkurt, U. Braun, S. Leferink, G. Gilly, G. Lux.
Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis.
Gut, 35 (1994), pp. 1132-1136
[33.]
M.A. Salam, K. Martin, N. Matsumoto, Y. Tsuha, N. Hanada, H. Senpuku.
E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice.
J Immunol, 173 (2004), pp. 4908-4918
[34.]
K. Takeuchi, Y. Hori, T. Hayakawa, H. Hashimoto, T. Atsumi, K. Hirose, et al.
A case of an old woman with Sjögren's syndrome associated with insulin-dependent diabetes mellitus.
Rumachi, 36 (1996), pp. 769-774
[35.]
M. Ramos-Casals, P. Brito-Zerón, A. Siso, A. Vargas, E. Ros, A. Bove, et al.
High prevalence of serum metabolic alterations in primary Sjögren's syndrome:influence on clinical and immunological expression.
J Rheumatol, 34 (2007), pp. 754-761
[36.]
A. Bateman, M. Deheragoda.
IgG4-related systemic sclerosing disease- an emerging and under-diagnosed condition.
Histopathology, 55 (2009), pp. 373-383
[37.]
L. Zhang, K. Notohara, M. Leby, S. Chari, T. Smyrk.
IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis.
Modern Pathology, 20 (2007), pp. 23-28
[38.]
Y. Makasi, L. Dong, N. Kurose, K. Kitaggawa, Y. Morikawa, M. Yamamaoto, et al.
Proposal for a new clinical entity IgG4 positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.
Ann Rheum Dis, 68 (2009), pp. 1310-1315
Copyright © 2011. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?